PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 5, 20260 citations

Fistula Calprotectin as a Biomarker of Local Inflammation and Treatment Response in Perianal Fistulizing Crohn's Disease.

View Full Paper
RWRunqi WangYWYanglong WuDXDongbo Xu

Key Points

  • This research aims to evaluate fistula calprotectin (FiCP) as a biomarker for inflammation and treatment response in perianal fistulizing Crohn's disease.
  • Evaluated the relationship between FiCP levels and local inflammatory activity.
  • Assessed the dynamic tracking of treatment response using FiCP as a biomarker.
  • FiCP levels correlated with local inflammation in perianal fistulizing Crohn's disease.
  • FiCP effectively monitored treatment response, indicating its potential clinical utility.

Abstract

FiCP represents a minimally invasive, tract-specific biomarker that mirrors local inflammatory activity and dynamically tracks treatment response in pfCD. Multicenter validation is warranted to define its clinical utility.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wang et al. (2026) studied this question.

synapsesocial.com/papers/69a91db5d6127c7a504c0ceehttps://doi.org/10.1111/apt.70600
Ask AI
Helpful
Bookmark
Share
View Full Paper